Evidence map›Paper›PMID 41008602›Full record

ArticleBiomolecules2025

Metabolic Adaptations Determine the Evolutionary Trajectory of TOR Signaling in Diverse Eukaryotes.

Kyle Johnson, Dellaraam Pourkeramati, Ian Korf, Ted Powers

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kyle JohnsonDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, CA 95616, USA.
Dellaraam PourkeramatiDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, CA 95616, USA.
Ian KorfDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, CA 95616, USA.ORCID 0000-0001-5259-6182
Ted PowersDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, CA 95616, USA.ORCID 0000-0002-2007-3819

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eukaryotes use diverse nutrient acquisition strategies, including autotrophy, heterotrophy, mixotrophy, and symbiosis, which shape the evolution of cell regulatory networks. The Target of Rapamycin (TOR) kinase is a conserved growth regulator that in most species functions within two complexes, TORC1 and TORC2. TORC1 is broadly conserved and uniquely sensitive to rapamycin, whereas the evolutionary distribution of TORC2 is less well-defined. We built a sensitive hidden Markov model (HMM)-based pipeline to survey core TORC1 and TORC2 components across more than 800 sequenced eukaryotic genomes spanning multiple major supergroups. Both complexes are present in early-branching lineages, consistent with their presence in the last eukaryotic common ancestor, followed by multiple lineage-specific losses of TORC2 and, more rarely, TORC1. A striking pattern emerges in which TORC2 is uniformly absent from photosynthetic autotrophs derived from primary endosymbiosis and frequently lost in those derived from secondary or tertiary events. In contrast, TORC2 is consistently retained in mixotrophs, which obtain carbon from both photosynthesis and environmental uptake, and in free-living obligate heterotrophs. These findings suggest that TORC2 supports heterotrophic metabolism and is often dispensable under strict autotrophy. Our results provide a framework for the evolutionary divergence of TOR signaling and highlight metabolic and ecological pressures that shape TOR complex retention across eukaryotes.

Indexed as

EukaryotaEvolution, MolecularMechanistic Target of Rapamycin Complex 2Signal TransductionTOR Serine-Threonine KinasesMechanistic Target of Rapamycin Complex 1PhylogenyMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2TOR Serine-Threonine Kinasesautotrophyeukaryotic evolutionheterotrophymetabolismmixotrophyphylogenomicsTOR signaling

Identifiers

PMID41008602
PMCPMC12467227

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.